Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ·Healthcare·Biotechnology
$734.06
-1.39%
Mkt Cap $77.87B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Jan 30, 2026 | $3.81B | $3.88B | +1.93% | $10.74 | $11.44 | +6.52% | — | — |
| Q4 2025 Oct 28, 2025 | $3.59B | $3.75B | +4.51% | $9.65 | $11.83 | +22.59% | — | — |
| Q3 2025 Aug 1, 2025 | $3.29B | $3.68B | +11.78% | $8.43 | $12.89 | +52.91% | — | — |
| Q2 2025 Apr 29, 2025 | $3.25B | $3.03B | -6.75% | $8.62 | $8.22 | -4.64% | — | — |
| Q1 2025 Feb 4, 2025 | $3.74B | $3.79B | +1.25% | $11.21 | $12.07 | +7.67% | — | — |
| Q4 2024 Oct 31, 2024 | $3.67B | $3.72B | +1.25% | $11.69 | $12.46 | +6.59% | — | — |
| Q3 2024 Aug 1, 2024 | $3.38B | $3.55B | +4.83% | $10.61 | $11.56 | +8.95% | — | — |
| Q2 2024 May 2, 2024 | $3.23B | $3.15B | -2.49% | $10.17 | $9.55 | -6.10% | — | — |
| Q1 2024 Feb 2, 2024 | $3.29B | $3.43B | +4.25% | $10.73 | $11.86 | +10.53% | — | — |
| Q4 2023 Nov 2, 2023 | $3.22B | $3.36B | +4.40% | $10.72 | $11.59 | +8.12% | — | — |
| Q3 2023 Aug 3, 2023 | $3.02B | $3.16B | +4.68% | $9.84 | $10.24 | +4.07% | — | — |
| Q2 2023 May 4, 2023 | $3.00B | $3.16B | +5.39% | $9.25 | $10.09 | +9.08% | — | — |
| Q1 2023 Feb 3, 2023 | $3.12B | $3.41B | +9.27% | $10.03 | $12.56 | +25.22% | — | — |
| Q4 2022 Nov 3, 2022 | $2.92B | $2.94B | +0.71% | $9.48 | $11.14 | +17.51% | — | — |
| Q3 2022 Aug 3, 2022 | $2.79B | $2.86B | +2.25% | $8.53 | $9.77 | +14.54% | — | — |
| Q2 2022 May 4, 2022 | $2.69B | $2.97B | +10.22% | $9.74 | $8.93 | -8.32% | — | — |
| Q1 2022 Feb 4, 2022 | $4.56B | $4.95B | +8.53% | $18.35 | $21.32 | +16.19% | — | — |
| Q4 2021 Nov 4, 2021 | $2.69B | $3.45B | +28.54% | $10.10 | $14.37 | +42.28% | — | — |
| Q3 2021 Aug 5, 2021 | $3.92B | $5.14B | +31.19% | $17.53 | $25.80 | +47.18% | — | — |
| Q2 2021 May 6, 2021 | $2.65B | $2.53B | -4.44% | $9.00 | $9.89 | +9.89% | — | — |